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Within the motoneuron precursor (pMN) domain of the developing spinal cord, the bHLH transcription factor, Olig2, plays critical roles in
pattern formation and the generation of motor neuron and oligodendrocyte precursors. How are the multiple functions of Olig2 regulated? We
have isolated a large BAC clone encompassing the human OLIG2 locus that rescues motor neuron and oligodendrocyte development but not
normal pattern formation in Olig2−/− embryos. Within the BAC clone, we identified a conserved 3.6 kb enhancer sub-region that directs reporter
expression specifically in the motor neuron lineage but not oligodendrocyte lineage in vivo. Our findings indicate complex regulation of Olig2 by
stage- and lineage-specific regulatory elements. They further suggest that transcriptional regulation of Olig2 is involved in segregation of pMN
neuroblasts.
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Neural tubeIntroduction
During vertebrate central nervous system (CNS) develop-
ment, multipotent precursors give rise to sequential waves of
progeny in response to regionally restricted cues and temporally
regulated factors (Anderson, 2001; Temple, 2001). Conceptu-
ally, this process can be divided into patterning, neurogenic and
gliogenic phases. Sonic hedgehog (Shh) signaling is essential
for pattern formation and instructs naive progenitors to adopt
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(Jessell, 2000). Function of Olig2, encoding a Shh-regulated
bHLH protein (Lu et al., 2000) is necessary to establish the
identity of the “pMN” domain, which is the source of motor
neuron (MN) and oligodendrocyte (OL) precursors in the
ventral neural tube (Mizuguchi et al., 2001; Novitch et al., 2001;
Lu et al., 2002; Park et al., 2002; Takebayashi et al., 2002; Zhou
and Anderson, 2002; Zhou et al., 2000).
In addition to early roles in neural pattern formation, Shh and
retinoic acid signaling regulate the subsequent generation of
MN from pMN progenitor cells (Marti et al., 1995; Roelink et
al., 1995; Novitch et al., 2003). The requirement for Shh
signaling extends into S-phase of the final progenitor cell
division during which Shh drives differentiation into MN
(Ericson et al., 1996). Additionally, ongoing Shh activity is
needed in the gliogenic phase for specification of OLP (Orentas
et al., 1999; Soula et al., 2001). The finding that Olig2 function
is required for generation of motor neuron and oligodendrocyte
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development of these lineages (Mizuguchi et al., 2001; Novitch
et al., 2001; Lu et al., 2002; Park et al., 2002; Takebayashi et al.,
2002; Zhou and Anderson, 2002).
Olig2 expression in the neural tube is bi-phasic with peak
levels corresponding the major periods of MN and OLP
specification at 9.5 and 12.5 days post coitum (dpc),
respectively (Sun et al., 2001). During the neurogenic phase,
Olig2 is expressed in proliferating pMN precursors and a subset
of Olig2+ cells co-express Lhx3 and Ngn2 in neuroblasts
(Mizuguchi et al., 2001; Novitch et al., 2001; Zhou et al., 2001).
While the mechanisms underlying early segregation of pMN
neuroblasts in the vertebrate neural tube are incompletely
understood, recent work has implicated ongoing effects of
Hedgehog signaling in conjunction with temporally regulated
factors (Park et al., 2004).
In contrast, less is known about intrinsic regulatory elements
for the genes that regulate pattern formation and fate choice. We
have focused transcriptional regulation of Olig2 at early stages
of CNS development. We achieved rescue of motor neurons and
oligodendrocytes in Olig2 null mutant animals in a dose-depen-
dent manner using a human Bacterial Artificial Chromosome
(BAC) encompassing the OLIG2 locus, and have identified a
functionally conserved 3.6 kb motoneuron lineage-specific
regulatory element. Our data leads to the proposal that regulation
is complex with separable regulatory elements for patterning,
neurogenesis and gliogenesis. Further, they implicate direct
regulation ofOlig2 in the process of neuroblast segregation from
a pool of pMN precursors in the vertebrate embryo.Materials and methods
Screening of the human BAC library
Human Bacterial Artificial Chromosomes (BAC) containing human
genomic sequences for OLIG2 and/or OLIG1 were screened from a human
high density BAC library (Research Genetics, Invitrogen) using the mouse
Olig2 cDNA as a probe. Three positive clones were identified and only one
(2401C4) can be expanded for maxi-preparation of BAC DNA. BAC-2401C4
was end-sequenced using T7 and Sp6 primers. The position of BAC-2401C4 on
human chromosome 21 was aligned with other BAC clones covering human
OLIG2 and OLIG1. Transcription factor binding site analysis was done with
MatInspector Professional.
Generation of transgenic mice
BAC DNA was prepared using a BAC maxi-preparation kit from the
Clontech. The BAC transgenic mice were generated by microinjecting BAC
DNA into fertilized oocytes (1-cell embryos), and transgenic founders were
identified by PCR and Southern blot analysis of tail-tip DNA. The integrity of
BAC DNAwas examined by both PCR and Southern Blots (The sequences of
PCR primers are available upon request). Five transgenic lines were generated
and two stable lines (lines 32 and 34) transmitted through the germline. The
expression of BAC transgene was examined using a human specific probe by in
situ hybridization. The human specific probes for OLIG2 and OLIG1 were
amplified within the 3′-untranslated regions (3′-UTRs) for each gene using PCR.
H-OLIG1-3′-UTR: 5′-TCGAACCTTCCAGTCCAGAG-3′ and 5′-CTACG-
TATGTAGCTCTTCAACTG-3′. H-OLIG2-3′-UTR: 5′-GACCTGATC-
GAGCGCTGTCTGG-3′ and 5′-GAAGGGTGTTACACGGCAGACG-3′.
The DNA constructs with positive activity in the ventral chick neural tube
were microinjected into fertilized mouse oocytes to generate OLIG2 enhancer-lacZ transgenic mice. Transgenic founders (n = 3) were identified by PCR to
amplify a 250 bp lacZ segment (lacZ-F: 5′-TTTAACGCCGTGCGCTGTTCG-
3′; lacZ-R: 5′-GATCCAGCGATACAGCGCGTC-3′). The transmission of the
K23-lacZ transgene was analyzed by staining the neural tube with β-
galactosidase. The OLIG2/K23 enhancer-cre line was generated by the
microinjection of fertilized mouse oocytes and transgenic founders were then
crossed with the ROSA-26 reporter line. The transmission of the transgene was
analyzed by staining the neural tube with β-galactosidase.
Analysis of K23 DNA regulatory sequences
Human, mouse, rat, and dog alignment was downloaded from the USCS
genome browser (http://genome.ucsc.edu/) using the hg16/mm4/rn2/canFam0
assembly. Transcription factor binding sites were identified using the
TRANSFAC database (http://www.genomatix.de).
BAC transgene copy number and motor neuron rescue
To determine transgene copy number, part of the 5′-UTRs of the human and
mouse Olig2 genes were co-amplified by PCR using the following primers: 5′-
ACACTCACCGCWGCATC-3′ and 5′-CACCAGGCTGGCGTCCGAGTC-3′.
PCR products were removed during the logarithmic phase of amplification (after
20, 22, 24, 26 and 28 cycles) and electrophoresed on a 2% (w/v) agarose gel.
This PCR reaction will generate two bands: a 707-bp human band and a 623-bp
mouse band. The intensity of each band was measured and quantified on a
SpotDenso program (Apha Innotech Corporation, model 2.1.3.).
Heterozygous Olig2+/− mutant mice were crossed with hemizygous human
BAC transgenic mice from lines #32 and #34 and sibling-mated to generate
heterozygous Olig2+/−; BACTg/+ offspring or homozygous Olig2−/−; BACTg/+
offspring. Genotypes were determined, retrospectively, by PCR on tail-tip DNA.
To quantify MN rescue, numbers of Hb9+ and Isl1+ MN in one side of the spinal
cord were counted from more than 10 sections taken at different anterior–
posterior levels of three animals of the genotypes indicated in Fig. 2 (n = 9
animals in total). The average and standard deviation of MN numbers were
calculated to determine level of significance.
Enhancer screen and forced expression in the chick neural tube
For the enhancer screen, human BAC DNA was digested with KpnI and
then randomly sub-cloned into a vector containing WntI minimal promoter,
WntI 110 bp minimal enhancer and lacZ. The insert of each DNA construct
was sequenced to localize its position on BAC DNA. The chick neural tubes at
Hamburger and Hamilton (HH) stage 10–12 were electroporated unilaterally
(five 50 ms pulses at 25 V) with DNA construct (3 μg/μl) using an ECM830
electroporator (BTX Inc.). For co-electroporation, equal amounts of plasmid
DNA (3 μg/μl each) were mixed before electroporation. Embryos were
analyzed after 48 h incubation (HH stages 21–23) by in situ hybridization
(ISH) and immunohistochemistry (IHC) after cryosectioning or stained in
whole mount with β-galactosidase for the reporter constructs. At least ten
electroporated embryos were analyzed for each plasmid DNA construct and
results documented in the figures are representative of at least five positive
embryos.
Tissue preparation, immunohistochemistry and in situ hybridization
Mouse embryos were collected at different ages according to the assumption
that mating occurred at midnight with plug detection at the following noon
(embryonic day 0.5). Embryos were fixed in 4% paraformaldehyde (PFA) in
Phosphate Buffered Saline (PBS, pH 7.0), embedded in OCT and cryosectioned
at 10–14 μm. For immunohistochemistry on sections, the following primary
antibodies were used at the indicated dilutions: mIsl1 (1:50, DSHB), mMNR2/
Hb9 (1:50, DSHB), mNkx2.2 (1:500, DSHB), Olig2 (1:4000), Lhx3 (1:100,
DSHB), Chx10 (1:5000, gift from C. Cepko, Harvard Medical School). The
secondary antibodies were anti-mouse IgG FITC (1:100, Jackson) and anti-
rabbit IgG Cy3 (1:200, Jackson). Photomicrographic images were collected on a
Nikon E600 microscope and RT Monochrome SPOT digital camera. In situ
hybridization was performed using a modified protocol of (Ma et al., 1997) and
154 T. Sun et al. / Developmental Biology 292 (2006) 152–164digoxygenin (DIG)-labeled antisense mRNA probe for Olig1, Olig2, PDGFRα,
Sox10, PLP/DM20, MBP, hOLIG2-3′-UTR and hOLIG1-3′-UTR. Detailed
instructions are available upon request.Results
Regulatory sequences within a 116 kb human BAC transgene
recapitulate aspects of endogenous Olig2 expression
To identify cis-acting regulatory sequences for Olig2, we
took advantage of a human BAC library to generate BAC
transgenic mice (Heintz, 2001). Human OLIG2 lies on
Chromosome 21 and a clone containing human OLIG2 coding
sequence was identified using a mouse Olig2 probe under low
stringency. BAC #2401C4 (Research Genetics), called BAC τ1
was end-sequenced and aligned with known BAC clones in
Genbank, such as AP000041 and AP001716, to identify the
precise locations for OLIG1 and OLIG2. As shown (Fig. 1A),Fig. 1. A human bacterial artificial chromosome (BAC τ1) containing OLIG2 recapitu
structure of the OLIG2 locus 42 kb from OLIG1 on human chromosome 21 and sequ
sequenced and aligned with published BAC clone sequences as shown. (B) Expre
transgenic mice. Expression of mouseOlig2 and humanOLIG2 by in situ hybridizatio
Expression of human OLIG2 is first detected at 9.5 dpc at caudal, but not rostral, leve
of rostral spinal cord is comparable to that of human OLIG2 expression in the T
throughout the spinal cord. Expression of hOLIG2 transcripts was observed in a subBAC τ1 comprises approximately 70 kb of sequence upstream
of OLIG2 and 43 kb of downstream sequence as well as OLIG2
andOLIG1 genes. The identity of the BAC τ1 was confirmed by
PCR using primers covering different regions on the BAC. It
was then used to generate transgenic mice by pronuclear
microinjection. Of 40 pups screened, five transgenic founders
were identified and two of these (lines 32 and 34) transmitted
the BAC transgene to progeny.
To characterize human OLIG2 expression driven by BAC-
encoded regulatory sequences, we used a species-specific
probe generated against the 3′ untranslated region of human
OLIG2. BAC τ1-driven expression of OLIG2 commenced at
9.5 dpc in the caudal spinal cord (Fig. 1B). At 11.5 dpc,
human OLIG2 mRNA transcripts were detected at rostral
(forelimb) levels, a similar pattern to endogenous Olig2. At
17.5 dpc, the human OLIG2 transgene, like the endogenous
mouse Olig2, was also expressed in scattered cells evenly
distributed in the spinal cord, and such expression co-localizedlates aspects of endogenous Olig2 expression in mice. (A) Cartoon showing the
enced human BAC clones. Of these, BAC-2401C4 (called “BAC τ1”) was end-
ssion analysis of human-specific OLIG2 mRNA transcripts in situ in BAC τ1
n is shown for wild type and BAC transgenic (Tg) mice at 9.5, 11.5 and 17.5 dpc.
ls of the spinal cord. At 11.5 dpc, expression of mouse Olig2 in the pMN domain
g mice (black arrowheads). At 17.5 dpc, Olig2-expressing OLP are dispersed
set (approximately 60%) of Olig2 expressing cells (insert).
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(Fig. 1B, see inset). We were unable to detect human OLIG1
expression in either BAC transgenic line (data not shown).
These findings indicate that BAC τ1 contains regulatory
elements sufficient to recapitulate important aspects of endog-
enous Olig2 expression.
Rescue of motor neuron and oligodendrocyte precursor
development in Olig2−/− mutant mice by BAC τ1
Motor neurons fail to develop in the spinal cord of
Olig2−/− embryos (Lu et al., 2002; Park et al., 2002;
Takebayashi et al., 2002; Zhou and Anderson, 2002) and no
cells expressing the MN markers Isl1, Isl2 or Hb9 are
detectable in Olig2−/− mutants at 14.5 dpc (Lu et al., 2002).
To assess whether BAC-encoded human OLIG2 transgene
functions during the neurogenic phase in mice, we intercrossed
BAC τ1-transgenic mice (line 34) with Olig2+/− heterozygotes
to obtain Olig2−/− BACTg34/+ animals. As shown (Fig. 2A),
Olig2−/− BACTg34/+ animals contained surviving Isl1- and
Hb9-positive cells, though in markedly reduced numbers
compared to Olig2+/− BACTg34/+ heterozygous littermates at
14.5 dpc (Fig. 2C). Similar results were obtained at 11.5 dpc
(not shown). Given that Olig1 is incapable of supporting MN
specification (Lu et al., 2002), these data indicate that human
BAC τ1 contains functional regulatory sequences for OLIG2
expression during neurogenesis.
The fact that only partial rescue of MN is achieved in
Olig2−/− BACTg34/+ animals might indicate different capabil-
ities of mouse and human OLIG2 proteins, or that BAC τ1Fig. 2. Rescue of motor neuron development in Olig2−/− mice by human BAC τ1. (A
neuron development in Olig2 null embryos. Addition of BAC 34Tg/+ was able to wea
Isl1 and Hb9). In contrast, BAC line 32 promotes more robust rescue of MN populati
analysis of BAC transgenic lines 32 and 34. The ratios of PCR products for human an
for human BAC transgene in lines 34 and 32 are two and three copies, respectively. (
Hb9+ cells in ventral neural tube were counted at ten different anterior–posterior l
significantly enhanced MN rescue compared with line 34 (P b 0.001). Control MNlacks regulatory sequences needed for robust expression of
OLIG2. To address the later point, we tested the effects of BAC
τ1 gene dosage on the degree of MN rescue. An independent
transgenic line was generated (line 32) with increased copy
number. The human OLIG2 PCR product was about 1.5 times
more abundant than the mouse Olig2 product, indicating that
three copies of OLIG2 had integrated per diploid mouse
genome in line 32, in contrast to two copies of the BAC in line
34 (Fig. 2B).
The large size of BACs makes them relatively insensitive to
position-dependent integration effects so that copy number
correlates well to expression levels (Yang et al., 1999; Heintz,
2001). Consistent with this, we observed stronger expression of
human OLIG2 mRNA transcripts in situ (Fig. 2A) and
detectable levels of OLIG2 proteins (data not shown) in
Olig2−/− BACTg32/+ relative to Olig2−/− BACTg34/+ animals.
Augmented rescue of MN numbers was achieved in Olig2−/−
BACTg32/+ animals (Fig. 2C). We observed spontaneous and
elicited motor activity only in Olig2−/− BACTg32/+ fetuses at
18.5 dpc; however none survived until weaning, reflecting
insufficient numbers of motor neurons generated in the
hindbrain and/or spinal cord or delayed development of MN
with resulting significant compromise of neurological function.
In contrast, Olig2−/− and Olig2−/− BACTg34/+ animals were
totally paralyzed. These data suggest that the degree MN rescue
in an Olig2 null background is correlated to the dosage of BAC-
encoded human OLIG2.
We used Isl1 and HB9 because previous studies have
shown they label most early motor neuron subtypes (Sharma
et al., 1998). We have detected Isl1+ and HB9+ motor) BAC transgenic lines 34 and 32 were assessed for their ability to rescue motor
kly rescue MN development at 14.5 dpc in Olig2−/− animals (MN markers used:
ons and appears to drive stronger levels of OLIG2 expression. (B) Copy number
d mouse OLIG2 were analyzed by the semi-quantitative PCR. The copy numbers
C) Quantitative analysis of MN rescue in BACTg/+, Olig2 null animals. Isl1+ and
evels from each of three animals. The increased BAC copy number in line 32
numbers in Olig2+/−, BAC 34 mice were equivalent to wild type.
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dpc, and increased Lhx3+ cells in the rescued spinal cord at
these stages (Supplementary Fig. 1 and data not shown).
Because Lhx3 can also be expressed in V2 interneurons, its
expression does not allow us to conclude any specific effects
of BAC τ1 on developing MN sub-populations.
Olig2 function is additionally required for specification of
oligodendrocyte precursors (OLP) in the neural tube (Lu et al.,
2002; Zhou and Anderson, 2002). Analysis with OLP markers
in Olig2−/− BACTg32/+ animals demonstrates delayed rescue of
this early phase of development (Fig. 3). However, oligoden-
droglia did not achieve expression of the intermediate mature,
PLP/DM20, nor the mature marker, myelin basic protein
(MBP), indicating a delay or block in OLP maturation. We
conclude that BAC τ1 contains regulatory sequences for Olig2
expression in precursors for both MN and OLP.Fig. 3. Rescue of oligodendrocyte precursor (OLP) development in Olig2−/− mice b
labeled by Sox10 (arrows). The lack of PDGFRα+ cells in the Olig2−/− BACTg32/+ ne
BAC can rescue OLP development (labeled by PDGFRα) at 16.5 and 18.5 dpc, the mBAC-τ1-driven expression of OLIG2 is insufficient to promote
normal patterning of the ventral neural tube
In the dorsal–ventral (D–V) axis of the embryonic neural
tube, motor neurons derive from the Olig2+ precursors of the
pMN domain (see Fig. 4G). The pMN is located ventral to the
V2 interneuron precursor (p2) domain and dorsal to the V3
interneuron precursor (p3) domain, demarcated by expression
of Nkx2.2. We thus investigated the nature of patterning in
Olig2−/− BACTg32/+ embryos, in which robust OLIG2
expression was only detected until 11–11.5 dpc at forelimb
levels of the spinal cord (Fig. 1). As shown (Fig. 4A), at 10.5
dpc Olig2+ cells were extremely difficult to detect in the pMN.
Indeed, identical to findings in Olig2−/− mutants (Lu et al.,
2002; Takebayashi et al., 2002; Zhou and Anderson, 2002),
we observed dramatically increased production of Chx10+y human BAC τ1. (A) BAC line 32 can rescue OLP development at 12.5 dpc,
ural tube indicates a delayed rescue of OLP development. (B) While the human
aturation of oligodendrocytes did not occur (labeled by PLP/DM20 and MBP).
Fig. 4. BAC τ1 fails to rescue normal pMN patterning in Olig2−/− mice. (A–C) Comparison of Olig2 expression and V2 IN development in Olig2+/− BACTg32/+
controls (top panels) andOlig2−/− BACTg32/+mutants (bottom panels) at 10.5 dpc. (A) Note extremely low/undetectable levels of OLIG2 proteins (green, arrow) in the
pMN region, which lies just dorsal to the Nkx2.2 (red)-expressing p3 domain. (B) Consistent with previously described patterning abnormalities in Olig2−/− embryos
(Lu et al., 2002; Zhou and Anderson, 2002), there is a marked increase in Chx10+ V2 (red) and (C) GATA3+ V2b interneuron cell production, reflecting ventral
expansion of the p2 domain (white brackets). (D) Comparison of Irx3 expression in control (left) andOlig2−/− BACTg32/+ (right) mice. Note that Irx3 expression (green)
abuts p3 progenitors that express Nkx2.2 (red). (E, F) Very rare Olig2+ and Ngn2+ cells were observed in the pMN region. (G) Despite these abnormalities, we
achieved partial rescue of MN development, indicating that OLIG2 expression is sufficient to establish MN precursor identity in the absence of normal pMN
patterning.
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Olig2−/− BACTg32/+ neural tube, indicative of ventralization of
the p2 domain (Figs. 4B and C). Irx3 is expressed in p2
precursor cells but not Olig2+ pMN cells. Ventral expansion
of the p2 domain in Olig2−/− BACTg32/+ embryos was
therefore confirmed by the observation of Irx3 cells abutting
Nkx2.2+ cells of the p3 domain (Fig. 4D). However, we did
observe rare Olig2+ cells in Olig2−/− BACTg32/+ mice,
suggesting that small isolated rests of Olig2+ cells are present
(Fig. 4E). Such rests could contribute to the early rescue of
Hb9+ cells and low levels of Ngn2-expression in 10.5 dpc
Olig2−/− BACTg32/+ mice. Nevertheless, it is clear that BAC-
τ1-driven expression of OLIG2 is insufficient to normally
pattern the pMN domain.Screen for OLIG2 enhancer elements that are functionally
conserved across species
We next sought to identify regulatory elements sufficient
to drive aspects of early OLIG2 expression in vivo. However,
given the large size of the candidate region in BAC τ1 (116
kb) and the fact that enhancer activities may be conserved
across species, we first employed a screening strategy of
electroporation into the E2 chick neural tube (Timmer et al.,
2001). Thirteen well-conserved intergenetic regions of BAC
τ1 between human and mouse genomes were cloned into a
lacZ-containing construct (Fig. 5A). The reporter gene
expression was tested 48 h after unilateral electroporation
by whole mount X-gal staining (Fig. 5B). As shown, lacZ
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Fig. 6. Olig2/K23-cre fate map in the ventral neural tube. (A) (top) Scheme for Olig2-enhancer fate mapping. Olig2/K23-cre mice were crossed with the conditional
ROSA26 reporter line to fate map progeny cells with β-galactosidase proteins. (B) Initial activation of reporter activity in the neural tube is observed at the forelimb
level at 9.5 dpc. Expression was also observed in the hindgut consistent with the normal pattern of the Olig2 expression (Lu et al., 2000) (see Supplementary Fig. 2).
(C, D) Higher power views of neural tube indicates reporter activity in ventricular zone (VZ) precursors (black arrow) and laterally located cells. (E) Pattern of
conditional reporter activation at 11 dpc in whole mount. Note strong expression of β-galactosidase throughout the spinal cord and ventral hindbrain with a rostral limit
at the midbrain–hindbrain isthmus. Little expression is observed in the forebrain in contrast to the normal pattern of Olig2 expression. (F, G) In 50 μm vibratome
sections at the forelimb level, reporter activity is detected in pMN precursors of the VZ and a mature population in the mantle zone located laterally. (H) Co-localization
of β-galactosidase activity with Olig2 (black arrowheads) confirms appropriate dorsal–ventral restriction to the pMN. Rare β-galactosidase positive cells that did not
express Olig2 are indicated (white arrowhead). This suggests that K23-cre marks an initial step of Olig2 upregulation or pMN cells that subsequently downregulate
Olig2. (I) BrdU (black arrowheads) confirms co-expression of the reporter in proliferating pMN precursor cells.
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neural tube and it was co-localized with motor neurons
labeled with Isl1 (Fig. 5B). Six of the constructs tested
showed β-galactosidase expression in the ventral neural tube
and four of these were tested for cross-species activity in
transgenic mice (Supplementary Table 1). Of these, only
enhancer K23 was active in the developing CNS of founder
mouse transgenic embryos (n = 3).
The 3.6 kb K23 DNA regulatory sequences showed high
conservation amongst mammals and drove reporter lacZ
expression in mouse spinal cord and hindbrain from about 10
to 12.5 dpc (Fig. 5C and Supplementary Fig. 2). Co-
expression of the reporter in hindbrain Olig2+ progenitors was
confirmed (Fig. 5C). At more caudal levels of the neural tube,Fig. 5. Conserved regulatory sequences for Olig2 drive expression in the ventral spin
between mouse and human syntenic sequences on chromosomes 16 and 21, respectiv
into the reporter construct shown in B, which contained insulators from chicken β-glo
al., 1998) that was used to drive lacZ reporter gene expression. (B) Reporter constr
analysis by X-gal whole mount staining. In addition to dorsalWntI enhancer driven ex
tested showed ventral expression (black arrows; see Supplementary Table 1) and these
expression with motor neuron marker Isl1 in the ventral neural tube. f: floorplate. (C
staining at 11.5 dpc shows expression in spinal cord and hindbrain (white arrows).
(turquoise, black arrowheads) was observed in Olig2+ cells of the hindbrain. At fore
MN marker Hb9 (brown). (right) Reporter activity was detectable in pMN precursors
is indicated with black bars.K23 driven reporter expression was relatively weak and
restricted to scattered cells in a sub-population of the pMN
domain (Fig. 5C). Although Olig2 expression is rapidly
extinguished as MN precursors leave the cell cycle, we
observed β-galactosidase activity in MN of K23-lacZ
transgenic mice from 10.5 dpc until 12.5 dpc (Fig. 5C and
data not shown). This might reflect relative stability of β-
galactosidase proteins, or possibly that K23 regulatory
sequences lack DNA-binding sites for repressors of Olig2
expression in early MN. K23-driven β-galactosidase activity
was present at neurogenic, but not gliogenic, phases of pMN
development and was undetectable in OLP or OL of the
spinal cord, suggesting lineage-specific expression of K23 in
MN precursors.al cord. (A) Scheme showing the OLIG1 and OLIG2 loci and regions conserved
ely. The highly conserved (N50%) regions indicated with pink shade were cloned
bin locus, the minimalWntI promoter and theWntI 110 bp enhancer (Rowitch et
ucts were electroporated into the chick E2 neural tube and harvested at E4 for
pression, used as a positive control (black arrowheads), several of the constructs
were selected for further analysis in transgenic mice. Construct K23 showed co-
) Confirmation of K23 enhancer activity in transgenic mice. (left) Whole mount
Hb: hindbrain level, fl: forelimb level. (middle panels) β-galactosidase activity
limb levels, scattered X-gal+ pMN cells were observed before acquisition of the
(black arrow) and post-mitotic MN at 10.5 (red arrows) until 12.5 dpc. The pMN
160 T. Sun et al. / Developmental Biology 292 (2006) 152–164The 3.6 kb Olig2 enhancer drives lineage-specific expression in
motor neurons
A robust and stringent test of enhancer specificity is to
fate map all progeny deriving from its expression domain.
We used the K23 regulatory sequences to drive expression
of bacteriophage P1 cre recombinase and analyzed the
resulting pattern of activity after crosses with a conditionally
active ROSA26-STOP-lacZ reporter (Soriano, 1999) (Fig.
6A). As shown (Figs. 6B to D), β-galactosidase activity wasFig. 7. Olig2-cre activity drives MN-lineage specific expression. (A–C) Co-label
expressing cells are MN in the 11.5 dpc neural tube. Lower panels are the high pow
staining segregates away from expression of Nkx2.2, a proxy marker for Sim1+ V
expression in oligodendrocytes segregates away from K23-cre labeled progeny as sho
Additionally, co-labeling with Isl1 at 17.5 dpc (F) reveals that K23-cre fate maps to
sequences active only at a late phase of neurogenesis.observed in the ventral spinal cord at 9.5 dpc, and little
ectopic expression was noted outside of the neural tube at
all stages examined (Fig. 6E and Supplementary Fig. 3). At
11 dpc, β-galactosidase activity was restricted to proliferat-
ing precursors of the pMN and laterally located post-mitotic
neurons (Figs. 6F and G). We further confirmed that X-gal+
cells co-expressed Olig2 and the S-phase marker BrdU
(Figs. 6H and I). These data suggest that Olig2/K23-cre
allele is sufficient to drive expression in proliferating Olig2+
precursors.ing with the MN markers Isl1, Hb9 and Lhx3 indicates that β-galactosidase
er views of selected areas in upper panels. (D, E) In contrast, β-galactosidase
3 interneuron precursors, and Chx10, a V2 interneuron marker. (F, G) Olig2
wn by Olig2 co-staining in 17.5 dpc and postnatal day 5 (P5) mouse spinal cord.
some MN (filled arrows) but not all (unfilled arrows) MN, consistent with K23
161T. Sun et al. / Developmental Biology 292 (2006) 152–164At 11.5 dpc and later stages, more than 90% of X-gal stained
cells co-localized with the MNmarkers Isl1, Hb9 or Lhx3 (Figs.
7A to C). In contrast, such X-gal stained cells segregated away
from expression of Nkx2.2, a proxymarker for the domain of V3
IN, and Chx10, the V2 INmarker (Figs. 7D and E). Furthermore,
β-galactosidase activity did not overlap with Olig2-expressing
OLP at 17.5 dpc and P5, indicating that K23 enhancer has no
activity in the glial lineage (Figs. 7F and G). Together, these data
indicate that (1) Olig2/K23-cre expression is restricted to pMN
domain precursors and progeny, (2) that the K23 enhancer drives
expression in proliferating MN precursors and (3) that the
kinetics ofK23-cre activity corresponds to a peak period of pMN
neurogenesis (9.5–11.5 dpc). The Olig2/K23-cre fate map at
later stages remains confined to the MN lineage, confirming that
it becomes downregulated in the pMN before commencement of
the gliogenic phase at 12.5 dpc. Further, Isl1 co-labeling of K23-
cre fate mapped animals at 17.5 dpc indicates that certain
surviving Isl1+ MN (presumably from an early neurogenic
wave) fail to be marked by K23-cre. Together, these data suggest
that BAC-encoded OLIG2 rescues several classes of MN
developing at a late stage of neurogenesis and similarly that
K23-cre generally labels late developing MNs.
Discussion
Olig genes are expressed in the Shh-responsive pMN domain
of the embryonic neural tube that gives rise to motor neuron and
oligodendrocyte precursors in successive waves of progeny cell
production. Olig genes show ongoing expression during a Shh-
independent phase of fetal oligodendrogenesis (Lu et al., 2000;
Cai et al., 2005; Vallstedt et al., 2005), and in maturing
oligodendrocytes as well as cycling cortical precursors in the
adult rodent brain (Hack et al., 2005; KLL and DHR,
unpublished observations). Using BAC transgene rescue and
motoneuron lineage mapping approaches, we provide evidence
that independent regulatory sequences govern baseline expres-
sion of Olig2 during the patterning phase versus neurogenesis
and gliogenesis in the embryonic neural tube.
Olig2 functions in neurogenesis and gliogenesis additional to
pMN patterning
To investigate determinants of complex Olig2 regulation, we
analyzed cis-acting DNA regulatory sequences within a human
BAC construct (“BAC τ1”) that contained ∼70 kb of upstream
sequence and 40 kb of sequence downstream of OLIG2. In
transgenic mice, we found that BAC τ1-driven expression of
OLIG2 was undetectable during the period of pattern formation
(8–9.5 dpc) in the pMN of the mouse neural tube, suggesting
that regulatory elements for early pMN expression are located at
considerable distance from the OLIG2 ORF. Interestingly, we
did observe rare, scattered Olig2+ cells in the region of the pMN
ofOlig2−/− mice. Further, in a functional test of such sequences,
we achieved rescue of motor neuron and oligodendrocyte
precursor development in Olig2−/− animals. The competence to
form MN is temporally restricted (Yamada et al., 1993). Thus,
these data indicate that the human BAC-driven expression ofOLIG2 in neurogenesis occurs during this window in a spatially
appropriate manner. Our data further demonstrate that fully
normal patterning is dispensable for embryonic MN or OLP
development in vivo. Indeed, in support of this view, Bai et al.
(2004) have shown MN generation takes place in Gli-deficient
embryos despite gross patterning abnormalities in the ventral
neural tube.
Motor neuron generation is thought to depend on two critical
periods of Shh signaling: an early period during which naive
neural plate cells are converted into ventralized progenitors
(∼8–9.5 dpc) and a late period during which Shh drives MN
differentiation (Ericson et al., 1996). We cannot rule out that
small rests of Olig2+ cells, below level of detection, are present
in the pMN region of Olig2−/− BACTg/+ animals at early stages.
Indeed, we observed isolated Olig2+ and Ngn2+ cells within the
pMN region consistent with this possibility. Therefore, our
results do not allow us to conclude that MN generation can
occur independently of Olig2 activity in the early period. They
do, however, rule out that non-cell autonomous functions of
Olig2 are necessary for motor neuron generation in vivo.
The low levels of transgene expression we observed at 9.5 d.
p.c. is caused in part by the delay of activation of the human
OLIG2 transgene locus compared with the endogenous mouse
Olig2. The rostral-caudal gradient expression driven by the
human BAC transgene matches well with the endogenousOlig2
gene, i.e., Olig2 has higher expression levels in the caudal
relative to the rostral neural tube. These two facts account for
the low levels of hOLIG2 especially in the rostral neural tube.
The Olig2 antibody can recognize both human and mouse forms
of Olig2 proteins (Ligon et al., 2004). This point is also
established by analysis of human OLIG2 proteins in Olig2-null,
BAC transgenic mice (this study). Analysis of human BAC
transgene expression using both mRNA probes and antibody
consistently showed lower levels of BAC-encoded products
compared to endogenous mouse gene and protein levels. Our
results also argue against auto-regulation of OLIG2, because
levels of human OLIG2 mRNA transcripts are similar in an
Olig2 heterozygous or null background.
Evidence for dose-dependent effects of Olig2 during embryonic
MN development
We observed that sub-normal levels of Olig2 proteins
resulted in only partial rescue of the MN deficient in Olig2
null embryos. Dose-dependent effects of other bHLH proteins
have been observed outside of the CNS. For instance, E2A,
encoding the bHLH protein E47, is required for B-cell
lymphocyte specification, and E2A gene dosage regulates pro-
B cell numbers (Zhuang et al., 1996; Herblot et al., 2002).
Indeed, several lines of evidence suggest that increased Olig2
dosage contributes to MN development, possibly through
promoting expression of the proneural bHLH protein, Ngn2.
First, peak levels of Olig2 expression are observed at 9.5 dpc,
corresponding to the major period of embryonic MN
generation (Sun et al., 2001). Second, forced expression of
Olig2 results in increased numbers of MN (Novitch et al.,
2001). Third, misexpression of Olig2 in the neural tube leads
Fig. 8. Dynamic regulation of Olig2 during pMN and MN development. During
neural tube patterning, baseline levels of Olig2 expression are induced/
maintained by Shh signaling. Our results show that K23-Olig2 upregulation in
scattered, proliferating cells of the pMN at 9–11.5 d.p.c. is specific to
developing MN. Subsequently, endogenous Olig2 is downregulated as MN
precursors leave the cell cycle and acquire expression of Hb9 and Isl1. Fate
mapping analysis indicates that K23-cre labeled cells are dedicated to the MN
lineage as no expression in oligodendrocytes was observed. However, because
OLIG2-K23 activity is detected in proliferating neuroblasts (NB), our findings
do not distinguish between two models of MN lineage progression, either from a
bi-potent MN-OLP precursor (NG) or dedicated, independently segregating
motoneuroblast (N).
162 T. Sun et al. / Developmental Biology 292 (2006) 152–164to ectopic expression of Ngn2 (Mizuguchi et al., 2001;
Novitch et al., 2001), and Ngn2 expression is lacking in the
pMN domain of Olig1/2 compound null animals (Zhou and
Anderson, 2002).
Though our findings of dose-related MN rescue were
obtained in a “non-physiologic” Olig2−/− background, they are
consistent with the findings generated above with wild type
animals (Mizuguchi et al., 2001; Novitch et al., 2001). We
observed a significant increase in the number of rescued MNs
when the higher copy number BAC-τ1 transgene allele (line
32) was crossed into Olig2-deficient embryos. One possibility
is that higher Olig2 dosage results in augmented pMN
patterning and in turn a larger pool of competent precursor
cells. However, despite the fact that ∼70% of MN were rescued
in Olig2−/−BACTg32/+ mice (three BAC transgene copies)
compared with ∼25% rescue in Olig2−/−BACTg34/+ mice (two
copies) at 14.5 dpc, we found no evidence for normal pMN
patterning in either case. We therefore favor the alternate
possibility that Olig2 dosage must reach a critical threshold
within pMN cells to generate MN precursors and perhaps their
capabilities for self-renewal.
In distinction to the studies above, Lee et al. have proposed
that high levels of Olig2 inhibit a transcriptional program
leading to MN differentiation (Lee et al., 2005). One way to
reconcile these apparently disparate findings on Olig2 upregu-
lation during pMN development is to consider distinct early and
late stage effects of Olig2 dosage. For instance, it is possible that
early Olig2 upregulation is involved in the initial segregation of
pMN neuroblasts and activation of Ngn2, whereas subsequent
Olig2 downregulation is necessary for MN differentiation.
Further work is clearly needed to precisely quantify levels of
Olig2 in individual pMN cells and determine the full
consequences for cell fate acquisition during the neurogenic
and gliogenic periods.
cis-acting DNA regulatory sequences for regulation of Olig2 in
motoneuron but not oligodendrocyte precursors
A related mechanistic question is whether stage- and lineage-
specific expression of Olig2 is governed by separable regulatory
elements. We used cross-species comparison of intergenetic
regions in BAC τ1 to identify candidate enhancers and
functionally screened these by electroporation into the chick
neural tube (Timmer et al., 2001). Another screening strategy to
identify Olig2 cis-acting regulatory elements in embryonic stems
cells has recently been described (Xian et al., 2005). We found
evidence for differential Olig2 regulation during the neurogenic,
but not patterning or gliogenic phases of development through
characterization of the 3.6 kb K23 regulatory element, which lies
approximately 11 kb downstream of OLIG2 on human
Chromosome 21 (Fig. 5A). Because we observe purdurant β-
galactosidase activity lasting until 12.5 d.p.c. in MNs, it is
possible that K23 lacks DNA-binding sites for transcriptional
repressors of Olig2 immediately at the time of MN lineage
commitment. Nevertheless, the K23 regulatory element is
sufficient to recapitulate an important aspect of Olig2 regulation
in MN-dedicated precursor cells prior to cell cycle exit.The OLIG2/K23 regulatory element failed to mark OLP or
oligodendrocytes at any stage examined in four independent
transgenic lines, despite the fact that the BAC τ1 drove
expression in OLP and rescued oligodendrocyte development in
Olig2−/− mice. Results with OLIG2/K23-cre, in particular,
demonstrate that OLIG2 regulatory sequences for general pMN
patterning lie outside of the K23 region. Using both β-
galactosidase and highly sensitive cre recombinase reporter
alleles, we found that the K23 regulatory element drives
expression commencing at approximately 9.25–9.5 dpc in
scattered cells of the pMN domain. Cre fate mapping revealed,
moreover, that all K23 activity is restricted to the MN lineage.
Interestingly, such a specialized pMN cell type was previously
suggested by mapping analysis using retroviruses in chick
(Leber and Sanes, 1991). However, because retrovirus will label
proliferating cells, these data together do not ambiguously
distinguish between two possibilities: (1) Olig2-K23 upregula-
tion in segregating neuroblasts of the pMN or (2) a bi-potent
MN-OLP precursor that gives rise to a proliferating dedicate
neuroblast (see Fig. 8).
A common requirement for function of the transcription
factors Gli2 and Nkx6.1/6.2 has been shown for normal
development of MN and OLP (Qi et al., 2003; Cai et al.,
2005; Vallstedt et al., 2005). We speculate that these or
additional proteins (Supplementary Fig. 2) may function
directly upstream of Olig2. Recent work shows the pMN
163T. Sun et al. / Developmental Biology 292 (2006) 152–164domain to be heterogeneous both with respect to Olig2
expression levels and the potential of individual progenitor
cells (Lee et al., 2005, Park et al., 2004). Therefore, the mosaic
expression driven by K23 regulatory sequences appears
indicative of the molecular mechanisms underlying pMN
heterogeneity and an important clue towards identification of
upstream events. Further refinement of K23 sequences by
deletion analysis is underway and promises insight into
mechanisms that regulate MN-specific gene expression.
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